Navigation Links
Savient Pharmaceuticals Appoints David Y. Norton Interim Chief Executive Officer
Date:2/1/2012

Savient's website fifteen minutes prior to the start of the call to ensure adequate time for any downloads that may be necessary.

A telephone replay will be available from 11:15 a.m. Eastern Time on February 1, 2012 through 12:00 a.m. Eastern Time on March 1,  2012 by dialing:

Domestic:
(800) 585-8367
International:
(404) 537-3406
Conference ID:
48497482

ABOUT SAVIENT PHARMACEUTICALS, INC.
Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA® (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University ("Duke") and Mountain View Pharmaceuticals, Inc. ("MVP"). Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology used in the manufacture of KRYSTEXXA. MVP and Duke have been granted U.S. and foreign patents disclosing and claiming the licensed technology and, in addition, Savient owns or co-owns U.S. and foreign patents and patent applications, which collectively form a broad portfolio of patents covering the composition, manufacture and methods of use and administration of KRYSTEXXA.  Savient also manufactures and supplies Oxandrin® (oxandrolone tablets, USP) CIII in the U.S. For more information, please visit the Company's website at www.savient.com.

FORWARD-LOOKING STATEMENTS
All statements other than statements of historical facts included in this press release are forward-looking statements that are subject to certain risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in such statements. These risks, trends and uncertainties are in some instances beyond our control. Words such as "anticipate," "believe," "esti
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
8. Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
9. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
10. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
11. Savient Pharmaceuticals To Hold First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ... "Electrocardiogram (ECG) Devices - Global Trends, Estimates and ... http://photos.prnewswire.com/prnh/20130307/600769 Global Electrocardiogram ... by 2016. The North America ... share while Europe claims approximately ...
(Date:12/15/2014)... 12, 2014 Research and Markets ... http://www.researchandmarkets.com/research/ms3j8c/cardiac ) has announced the addition of the ...  report to their offering. Global Guidewires sector is ... North America accounts for nearly 35% ... claims approximately 25% (2018). Asia-Pacific ...
(Date:12/15/2014)... YORK and HERZLIYA PITUACH, Israel ... "Company") (NASDAQ: IMNP ) announced today that its ... the Board succeeding Dr. Daniel Teper who continues ... a member of Immune,s Board of Directors since 2013. ... "I am delighted to represent the interest of shareholders and ...
Breaking Medicine Technology:Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 2Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 3Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 4Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 2Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 3Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 4Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 3Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 4
(Date:12/19/2014)... December 19, 2014 B. E. Smith, ... healthcare providers, has been retained to lead a national ... Medical Center in Estes Park, Colo. The top executive ... has recently placed more than 900 healthcare executives into ... a 25-bed, not-for-profit critical access hospital and level IV ...
(Date:12/19/2014)... Hands On Mobile Spa, has announced they ... On Wheels has been transformed into a utopia for the ... seems to disappear. The Virtual Tour showcases the beauty of ... corporate events and more. , The Virtual Tour shows viewers ... is actually an overhauled Winnebago. Marla Kaplan-Pelle, Director states " ...
(Date:12/19/2014)... Slone Partners , a national recruitment firm ... and laboratory testing industries, has promoted Leslie Loveless ... announcement comes after a year of expansion by ... Boston and several new additions to the team. ... experience," said Adam Slone, Chief Executive Officer. “Diagnostics ...
(Date:12/19/2014)... 2014 The Hermitage Club at ... Southern Vermont’s Deerfield Valley, announced today that it has ... rock songs. , Three time Grammy Award Winner ... concert followed by a trail naming ceremony. Hermitage Club ... include: “I’m Alright” the theme song for the movie ...
(Date:12/19/2014)... HealthDay Reporter THURSDAY, Dec. 18, 2014 (HealthDay ... high levels of air pollution late in pregnancy may have ... Researchers found that of nearly 1,800 U.S. women who ... most air pollution during pregnancy were twice as likely to ... the third trimester, specifically, showed the strongest correlation to autism ...
Breaking Medicine News(10 mins):Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 3Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 2Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 3Health News:Slone Partners Promotes Leslie Loveless to Chief Operating Officer 2Health News:The Hermitage Club Officially Names Four Ski Trails after Iconic Rock Songs by Grammy Award Winner Kenny Loggins 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 3
... WASHINGTON, Feb. 1 The American Public,Health Association (APHA) ... of Congress voted on legislation that is,important to public ... of individual votes,and selecting key public health votes during ... In the Senate, 46 out of 100 senators voted ...
... the vital role wetlands play in society, they remain among ... and positive effects of healthy wetlands for humans, the theme ... 2 February, is Healthy Wetlands, Healthy People. , According to ... claims the lives of more than 3 million people every ...
... Clinton,Campaign today announced the endorsement of the American ... the nation,s 2.9 million,registered nurses., "Too many ... and this,country deserves a president that will make ... M. Patton, MSN, RN, CNOR. "Senator,Clinton has shown ...
... 1 The Beaumont Technology,Usability Center will begin ... Food and,Drug Administration,s study on tubing and catheter ... released a Sentinel Event Alert on the,potential dangers ... and one instance of permanent loss of function ...
... Corporation (Nasdaq: OSCI ) will release financial ... December 31, 2007 on,Wednesday, February 6, 2008 prior ... conference call will be held at 8:30 a.m. ... other members of Oscient,s,management team. The Company announced ...
... of Acne ... Treatment, ... MD and co-investigators Mikiko,Enokibori, MD, and Vic Narurkar, MD, conducted a ... of acne,ranging from mild and moderate inflammatory acne to severe nodular ...
Cached Medicine News:Health News:APHA Scores Members of Congress on Public Health Voting Record 2Health News:Connection between health of wetlands and humans in focus 2Health News:Connection between health of wetlands and humans in focus 3Health News:The American Nurses Association Endorses Senator Hillary Rodham Clinton (D-NY) 2Health News:FDA Renews its Contract with Beaumont Technology Usability Center for Leadership of Patient Safety Project 2Health News:Webcast Alert: Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results 2Health News:New Study Shows Isolaz Can Reduce Acne Up to 90 Percent 2Health News:New Study Shows Isolaz Can Reduce Acne Up to 90 Percent 3
One piece, 100% fused silica construction offers low scatter and high efficiency...
Stirrups provide a safe system for positioning patients in a variety of lithotomy positions. Power-assisted positioning, as well as abduction, assures proper positioning of the patient. Includes one ...
... radiolucent armboard with secure positive locking rail ... allows for easy vertical up and down ... O.R. Table surface without changing the pad. ... mounted on either side of O.R. Table, ...
... carbon fiber armboard is easily ... table siderail. Durable construction eliminates ... enclosed within molded body, protecting ... Molded carbon fiber allows for ...
Medicine Products: